Siemens launches PACS non-obsolescence program

Article

Siemens launches PACS non-obsolescence programSiemens Medical Systems moved to protect its customers’ PACS networks this month when it introduced its PACS non-obsolescence program. Iselin, NJ-based Siemens expects the program to help

Siemens launches PACS non-obsolescence program

Siemens Medical Systems moved to protect its customers’ PACS networks this month when it introduced its PACS non-obsolescence program. Iselin, NJ-based Siemens expects the program to help clients upgrade hardware and software at a fixed price, allowing PACS and information technology system networks to be upgraded over their life expectancy.

Siemens’ non-obsolescence program helps customers budget for PACS upgrades, provides two weeks of product engineering consulting per year, and allows access to Siemens’ service and applications staff. The company has already signed two clients to the program in deals estimated at more than $2 million: the Cleveland Clinic has a four-year agreement, while the Children’s Medical Center of Dallas has a five-year contract.

© 2000 Miller Freeman, Inc., a United News & Media company

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.